Diarrhea is commonly seen in patients treated with antimicrobial agents. This is often a reversible state and is caused by changes of the normal fecal flora.
A more serious form of diarrhea in connection with treatment by antimicrobial drugs is the socalled pseudomembranous enterocolitis (PMC), which has been described after treatment with tetracyclines, chloramphenicol, ampicillin, cephalosporins, and clindamycin (3, 10). Different bacteria, for example Staphylococcus spp., Pseudomonas spp., and Proteus spp., have been suggested to contribute to PMC (3). It has recently been suggested by Larson et al. (9) and Bartlett et al.
(1) that, in many cases, toxin-producing clostridia can cause PMC. Clostridium difficile has especially been associated with PMC (2).
C. difficile is a gram-positive, obligate anaerobic rod, which has been considered somewhat difficult to isolate. It was described as early as 1935 by Hall and O'Toole (6) and was considered nonpathogenic for humans until recently (1, 9).
C. difficile toxin has been detected in feces from 98% of patients with PMC and in 15% of patients with antibiotic-induced diarrhea without signs of PMC (2). Epidemiological studies on healthy individuals indicate that C. difficile can be isolated from stools in 2% of adults (11) . Bacterial cultivation. The selective and differential CCFA medium was used for the primary isolation of C. difficile (5) . Examination of the plates was performed after 48 h of incubation in anaerobic jars (6% C02, 94% H2). Suspected colonies were subcultured on blood agar plates (5% horse blood). All isolates were submitted to Gram stain and gas-liquid chromatography analysis (7) .
All isolates, as well as the reference strain ATCC 9689, are kept in the EF Culture Collection of this Institute.
Salmonella, Shigella, and Yersinia were cultivated using standard techniques, and the selective medium of Skirrow was used for isolation of C. fetus subsp. jejuni (12) . RESULTS C. difficile was isolated in 81 stool samples from 56 patients (22 females and 34 males). Of the 56 patients, 41 each had one stool sample positive for C. difficile, 8 had two samples positive, 6 had three samples positive, and 1 had six samples positive. The isolation frequency was 3% (81/2,390). The cases feU into three different age groups (Fig. 1) . Children 4 years old or less were included in the first age group (43%, 24/ 56), and, within this group, 67% (16/24) were less than 1 year old. Of these, 31% (5/16) were children adopted from abroad.
The second age interval (39%, 22/56) consisted of young and middle-age adults between 15 and 44 years of age (Fig. 1) . The third group (18%, 10/56) consisted of older people, 55 to 84 years of age.
A recent return from abroad was noted for 29%, 50%, and 10% of the individuals in the respective age groups (Table 1) . Records were made available for 42 patients. In most cases diarrhea was the reason for having a stool culture performed. In at least 48% of the patients (20/42), treatment with antimicrobial agents was performed before enteritis developed. The distribution in the young, middle, and old age groups was 42, 18, and 60%, respectively (Table  1) . Fourteen different antibiotics alone or in combination had been in use. Six patients received cotrimoxazole, five received phenoxymethylpenicillin, two received cephalothin, two received sulfonamide, and one each received flu-15 10'
Number of patients cloxacillin, carbenicillin, ampicillin, cefoxitin, cefuroxime, neomycin, clindamycin, metronidazole, and pivmecillinam.
Diarrhea was seen in 50 of the 56 patients (89%). Only six individuals had stool cultivations performed as a routine health control procedure, without presenting symptoms of enterocolitis. Of these, four were adopted children. Two patients had a severe enterocolitic disease without pseudomembranes. One of these, who suffered from chronic lymphatic leukemia, was intensively treated with several antimicrobial agents for septicemia and died after 2 weeks. The other patient was given ampicillin treatment for pyelitis before his enterocolitis. The remainder of the patients had moderate diarrhea for a period of 1 to 2 weeks; only a few were proctoscoped, and none was colonoscoped.
Positive tive medium is used. The characteristic odor of the bacterium is useful for the diagnosis. The bacteria were very vulnerable on the strongly selective medium, and all suspected colonies had to be subcultivated on nonselective media as soon as possible.
As judged from earlier reports, C. difficile can be isolated from stools from 2% of healthy individuals (11), which is approximately the isolation frequency in the present study. However, the majority of the patients from whom C. difficile was isolated did have diarrhea (50/56). Most patients had a moderate disease with mild diarrhea, and PMC was not identified in even the two patients with very severe diarrhea.
Antimicrobial treatment has been considered to induce PMC. In the present study, about 50% of the patients in whom C. difficile had been isolated had a recent period of antimicrobial treatment, but only 14% were treated with the antimicrobial agents reported to be especially correlated to PMC and the occurrence of C. difficile.
In the present study of patients with C. difficile, concomitant findings of intestinal bacterial pathogens were common. Our theory is, therefore, that PMC is a rare disease even in antimicrobial-treated patients developing diarrhea and in whom C. difficile is found. C. difficile might induce mild cases of diarrhea without pseudomembranes. Antimicrobial treatment or any gastrointestinal disorder where the normal bacterial flora of the intestines is changed seems to increase the possibilities for detection of C. difficile. In the present material, the patients in whom C. difficile was isolated were found in three age groups (Fig. 1) . This finding is in agreement with the above-mentioned theory for the following reasons.
In small children and elderly patients, there was a high frequency of recent treatment with antimicrobial agents (42 and 60%, respectively), which influences the normal intestinal flora. In the age group from 15 to 44 years of age, antibiotic treatment was only administered in 18% of the patients. In these individuals, however, concomitant findings of other intestinal bacterial pathogens were common: 50% as compared to 33 and 20%, respectively, of the individuals in the young and old age groups (Table 1) . Furthermore, the middle age group had more often been recently abroad (50% as compared to 29 and 10%), which may cause a change in the normal intestinal flora (Table 1 ).
In conclusion, the mere finding of C. difficile in most cases of diarrhea without signs of PMC should not be an indication of treatment directed against C. difficile. In the rare cases of PMC, usually in compromised patients, where treatment is indicated, vancomycin seems at present to be the drug of choice (8) .
